What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News Biomedical and Biotechnology Research UAB Forum The Biomedical and Biotechnology Research UAB Forum, held on 21 October, has pooled the entire biomedical and biotechnological research that takes place around the project UAB, to raise awareness of the skills, strategic projects for institutions and major research lines of the set of institutions, News SMD Integrated Diagnostic Workshop Units of Cytology, Immunophenotype and cytogenetics of Hematology from Hospital Vall d'Hebron organized on October 20 the first Integrated Diagnostics Workshop Myelodysplastic Syndromes (MDS) of clinical cases. The workshop, which involved 10 residents of the last year in Hematology, was led by Tere News Dr. Laporte explains his vision about drugs Dr Joan-Ramon Laporte, head of clinical pharmacology group at VHIR and responsible of the Catalan Institute of Pharmacology, explains his vision on drugs and other questions in TV3 and La Vanguardia. News Inauguration of the sculpture 'Life and creation' at Collserola Building On Tuesday October 19 took place the opening ceremony of the sculpture 'Life and creation', the work of artist Ramon Cuello, charged in connection with the opening of Collserola Building. The discovery of the sculpture outside the main entrance of Collserola Building preceded speeches from the manag News VHIR's director debates on the future of medicine Dr Joan X. Comella, director of Vall d'Hebron Research Institute (VHIR) participated in a debate on the future of medicine in the local television network (XTVL), where he offered the vision of translational research. 'Angles', a program moderated by journalist Jordi Sacristan, counted also with Al News Vall d'Hebron researchers present new strategies for preventing infections at ICU The ICU team at Hospital Vall d'Hebron and the research group of severe sepsis and respiratory infection in its Research Institute (VHIR), coordinated by Dr. Jordi Rello, have presented important developments at the Congress of the European Society of Intensive Care (ESICM), that has taken place the News VHIR supports CAIBER project Instituto de Salud Carlos III promoted since 2008 the project of Consortium to Support Biomedical Research Network (CAIBER) as a platform for clinical trials. CAIBER has already included forty of the more powerful and competitive health centers of the country, establishing frameworks for cooperation News EATRIS presents its infrastructure concept in Rome The EATRIS Conference “From Basic Research to Medical Innovation”, held in Rome 7-8 October, served to present the infrastructure concept of this program launched by the European Commission to support infrastructures for the biomedical sciences. After three years of frequent exchange and intense w News The health computerization project between VHIR and Ilimit receive an ACC1Ó grant The Catalonian company specialized in technology -Ilimint- has achieved an ACC1Ó grant to carry out together with the Institut de Recerca Hospital Universitari Vall d'Hebron in Barcelona (VHIR ) the R & D related to Information Technology (IT) applied to the health sector. This grant, which receives News Dr. Cabero reflections about 2010 Medicine Nobel Prize Dr. Luis Cabero, responsible for Maternal and Fetal Medicine at Vall d'Hebron Research Institute, expresses his views on the 2010 Medicine Nobel Prize for Robert G. Edwards, 'father' of fertilization in vitro. "It is a great tribute to Edwards work, that not only advances in conception, but also op News Identified one of the reasons for the neuronal death of patients with Parkinson Researchers from Vall d'Hebron Research Institute (VHIR) present the results of a study that explains how the presence of some abnormal clumps of proteins inside nerve cells is associated with neuronal death in Parkinson's patients. This research also raises, at an experimental level, a new therapeu News Low MBL level increases risk of subclinical graft rejection Trying to identify early the group of patients at increased risk of subclinical rejection of the graft is one of the challenges to improve outcomes after transplantation, hence useful predictors markers are sought. The MBL (Mannose Binding Lectin) protein has emerged as one of these biomarkers, suc News Dr. Morell at ERS The director of the Pneumology service at Hospital Vall d’Hebron, doctor Ferran Morell, took part with an oral presentation on the Congress of the European Respiratory Society (ERS), in Barcelona, from 18 to 22 September. "http://www.itbeganhere.com/firabcn/firanews/EN/smoking.html" More informati News VHIR's researchers develop a test to detect prostate cancer VHIR's researchers Marina Rigau, Andreas Doll and Jaume Reventós, together with Dr. Joan Morote, responsible of the Urology Service, have developed a test to improve the early detection of prostate cancer from an urine analysis. The test has determined in approximately two hundred men who came to t News Identified the genes responsible of the incomes for intensive care patients with A flu A research team from Vall d'Hebron Research Institute (VHIR) have studied the immunological answer in the patients who required income to Intensive Cares for severe pneumonia during the acute phase of the A flu. The conclusions of the study indicate that, in those most severe cases, the failure of t News Catalonian Health Minister opens Collserola Building, VHIR's new facilities Catalonian Health Minister, Marina Geli, opened on Wednesday 22 September the new facilities of Vall d'Hebron Research Institute (VHIR), Building Collserola. Building Collserola, made with the support of P.O. FEDER2007-2013, will host nearly 200 scientists in its 2500 m2, and complements the Medit News Stopping antiplatelet therapy after a drug active stent placement increases high risk of thrombosis Researchers from Vall d'Hebron Research Institute (VHIR) lead a study showing epidemiological data on the causes and consequences of noncompliance with antiplatelet therapy with platelet after placement of a drug-eluting stent or drug active stent. Due to the severity of the effects of stopping t News Alicia Koplowitz Foundation provides significant funds to a project coordinated by Dr. Comabella A project coordinated by Dr. Manuel Comabella, member of the Neuroimmunologia Group at Vall d'Hebron Research Institute (VHIR), in which also participates Rana Moubarak, a member of Cell Signaling and apoptosis research group, has received a substantial fund from the Alicia Koplowitz Foundation. T News Discovered new markers of risk and response to treatment in ictus The Neurvascular Laboratory of Vall d'Hebron Research Institute (VHIR) found some genetic variants that, on the one hand, represent an indicator of response to treatment in ictus as a marker and, secondly, is associated with increased risk for this disease. These results are the fruit of a long his News The scientific perspective on intersexuality Dr. Laura Audi, member of the Endicronology Paediatric Unit at Vall d'Hebron Research Institute (VHIR) gives her views on intersexuality. Years ago, it was assigned one sex to the baby that eventually, could be wrong. Now, thanks to advances in genetic, morphological and hormonal studies, is possib Pagination First page « Previous page ‹ … Page 151 Page 152 Current page 153 Page 154 Page 155 … Next page › Last page »
